SAMD9 抗体 (Cy5)
Quick Overview for SAMD9 抗体 (Cy5) (ABIN1418136)
抗原
See all SAMD9 抗体适用
宿主
克隆类型
标记
应用范围
-
-
交叉反应
- 人, 小鼠, 大鼠
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human SAMD9
-
亚型
- IgG
-
-
-
-
应用备注
- IF(IHC-P) 1:50-200
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- SAMD9 (Sterile alpha Motif Domain Containing 9 (SAMD9))
-
别名
- SAMD9
-
背景
-
Synonyms: SAM domain-containing protein 9, SAMD9, SAMD9_HUMAN, sterile alpha mot domain containing 9, Sterile alpha mot domain-containing protein 9, C7orf5.
Background: Defects in SAMD9 are the cause of normophosphatemic familial tumoral calcinosis (NFTC). NFTC is an uncommon life-threatening disorder characterized by massive periarticular, and seldom visceral, deposition of calcified tumors.
-
基因ID
- 54809
抗原
-